Pipeline suggests another busy year for Chinese IPOs in the US

Bank of New York Mellon's head of Asia-Pacific DRs says the bank is in talks with some 15 US listing candidates. He also expects innovative Asian products like HDRs, IDRs and Singapore's GlobalQuote board to develop further this year.

The first China IPO has yet to hit US markets this year, but an industry insider predicts another busy year as many small and mid-size private sector companies continue to favour a listing in New York via American depositary receipts ADRs over markets closer to home.

He is also positive that the key DR market innovations in Asia last year, including Indian DRs, Hong Kong DRs and the ability to trade ADRs in Singapore, will continue to develop...